title: Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
authors.affiliation: Department of Hematology-Oncology, Dicle University, Faculty of Medicine, 21100, Diyarbakir, Turkey. oayyldz@yahoo.com
authors.forename: Orhan
authors.initials: O
authors.lastname: Ayyildiz
authors.forename: Abdurrahman
authors.initials: A
authors.lastname: Isikdogan
authors.forename: Zahit
authors.initials: Z
authors.lastname: Bolaman
authors.forename: Ekrem
authors.initials: E
authors.lastname: Muftuoglu
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002423:Cause of Death; D002699:Chlorambucil / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D019233:Retreatment; D016019:Survival Analysis; D014421:Turkey; D014740:Vidarabine / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D002699:Chlorambucil; D011239:Prednisolone; D014740:Vidarabine; C024352:fludarabine